Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Reexamination Certificate
2004-07-29
2011-10-18
Hartley, Michael G (Department: 1618)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
C424S001890
Reexamination Certificate
active
08038983
ABSTRACT:
Disclosed are novel conjugates that include fluorinated carbohydrate molecules and methods for synthesizing the conjugates. The fluorinated carbohydrate molecule may include a radioisotope. The method of synthesizing the conjugate is useful for labeling selected molecules, and the conjugates may be useful in diagnostic or therapeutic methods. Particularly, the conjugates may be useful in diagnostic or therapeutic kits.
REFERENCES:
patent: 3471329 (1969-10-01), Nitsch et al.
patent: 3927193 (1975-12-01), Hansen et al.
patent: 4150149 (1979-04-01), Wolfsen et al.
patent: 4160675 (1979-07-01), Pannekeet et al.
patent: 4331647 (1982-05-01), Goldenberg
patent: 4348376 (1982-09-01), Goldenberg
patent: 4361544 (1982-11-01), Goldenberg
patent: 4361644 (1982-11-01), Urban et al.
patent: 4444744 (1984-04-01), Goldenberg
patent: 4460459 (1984-07-01), Shaw et al.
patent: 4460561 (1984-07-01), Goldenberg
patent: 4468457 (1984-08-01), Goldenberg et al.
patent: 4624846 (1986-11-01), Goldenberg
patent: 4735210 (1988-04-01), Goldenberg
patent: 4818709 (1989-04-01), Primus et al.
patent: 4932412 (1990-06-01), Goldenberg
patent: 5019368 (1991-05-01), Epstein et al.
patent: 5091542 (1992-02-01), Ahlem et al.
patent: 5101827 (1992-04-01), Goldenberg
patent: 5128119 (1992-07-01), Griffiths
patent: 5262524 (1993-11-01), Anderson et al.
patent: 5308944 (1994-05-01), Stone-Elander et al.
patent: 5328679 (1994-07-01), Hansen et al.
patent: 5332567 (1994-07-01), Goldenberg
patent: 5435990 (1995-07-01), Cheng et al.
patent: 5525338 (1996-06-01), Goldenberg
patent: 5633425 (1997-05-01), Lonberg et al.
patent: 5635603 (1997-06-01), Hansen et al.
patent: 5697902 (1997-12-01), Goldenberg
patent: 5716595 (1998-02-01), Goldenberg
patent: 5736119 (1998-04-01), Goldenberg
patent: 5746996 (1998-05-01), Govindan et al.
patent: 5753206 (1998-05-01), McBride et al.
patent: 5767285 (1998-06-01), Hamann et al.
patent: 5772981 (1998-06-01), Govindan et al.
patent: 5776093 (1998-07-01), Goldenberg
patent: 5776094 (1998-07-01), Goldenberg
patent: 5776095 (1998-07-01), Goldenberg
patent: 5808020 (1998-09-01), Ferrieri et al.
patent: 5827690 (1998-10-01), Meade et al.
patent: 5837242 (1998-11-01), Holliger et al.
patent: 5851527 (1998-12-01), Hansen
patent: 5874540 (1999-02-01), Hansen et al.
patent: 5882626 (1999-03-01), Epstein et al.
patent: 5892020 (1999-04-01), Mezes et al.
patent: 5904915 (1999-05-01), Fujibayashi et al.
patent: 5922302 (1999-07-01), Goldenberg et al.
patent: 5932178 (1999-08-01), Yamazaki et al.
patent: 5965132 (1999-10-01), Thorpe et al.
patent: 6004554 (1999-12-01), Thorpe et al.
patent: 6010680 (2000-01-01), Govindan et al.
patent: 6017514 (2000-01-01), Epstein et al.
patent: 6025165 (2000-02-01), Whitlow et al.
patent: 6071491 (2000-06-01), Epstein et al.
patent: 6077499 (2000-06-01), Griffiths et al.
patent: 6096289 (2000-08-01), Goldenberg
patent: 6126916 (2000-10-01), McBride et al.
patent: 6342221 (2002-01-01), Thorpe et al.
patent: 6387350 (2002-05-01), Goldenberg
patent: 6962813 (2005-11-01), Pier et al.
patent: 7098302 (2006-08-01), Krag et al.
patent: 0 167 103 (1985-06-01), None
patent: 1034797 (2000-09-01), None
patent: 03/059397 (2003-07-01), None
patent: WO 03078454 (2003-09-01), None
patent: 03/086475 (2003-10-01), None
patent: 2005/028490 (2005-03-01), None
Patt et al. (Applied Radiat.Isotopes 2002, 57, 705-712).
Cervigni et al. (Angew. Chem. Int. Ed. Engl. 1996, 35, 1230-1232).
King et al. (Biochemistry 1986, 25, 5774-5779).
Karacay et al. (Bioconj. Chem. 2000, 11, 842-854).
Andreana et al.,Org. Lett., 4(11):1864 (2002).
Arcamone,Cancer Res., 45:5995 (1985).
Bakina et al.,J. Med. Chem., 40:4013 (1997).
Barbas et al.,Methods: A Companion to Methods in Enzymology, 2:119 (1991).
Bei et al.,J. Immunol. Meth., 186:245 (1995).
Beuthien-Baumann et al.,Carbohydrate Res., 327:107 (2000).
Carter et al.,Proc. Nat'l Acad. Sci. USA, 89:4285 (1992).
Colman,Biochem. Soc. Symp., 63:141, 1998.
Coloma et al.,Nat. Biotech., 15:159 (1997).
Courtenay-Luck et al., “Genetic Manipulation of Monoclonal Antibodies”,Monoclonal Antibodies: Production, Engineering, and Clinical Application, pp. 166-179, Ritter (eds.), Cambridge University Press (1995).
Fiedler et al.,Biotechnol., 13:1090 (1995).
Fiedler et al.,Immunotechnol., 3:205 (1997).
FitzGerald et al.,Protein Eng., 10(10):1221 (1997).
Hande et al.,Cancer Res., 48:1829 (1988).
Hasan et al.,Prog. Clin. Biol. Res., 288:471 (1989).
Jackson et al.,Brit. J. Cancer Res., 78(2):181 (1998).
Jones et al.,Nature, 321:522 (1986).
Kaneko et al.,Bioconjug. Chem., 2(3):133 (1991).
Kostik et al.,J. Org. Chem., 66:2618 (2001).
Larrick et al.,Methods: A Companion to Methods in Enzymol., 2(2):106 (1991).
Mack et al.,Proc. Natl. Acad. Sci. USA, 92:7021 (1995).
Mahiouz et al.,J. Immunol. Meth., 212:149 (1998).
Mendez et al.,Nat. Genet., 15:146 (1997).
Mew et al.,J. Immunol., 130:1473 (1983).
Mew et al.,Cancer Res., 45:4380 (1985).
Miller et al.,Ann. Rev. Microbiol., 42:177 (1988).
Orlandi et al.,Proc. Nat'l Acad. Sci. USA, 86:3833 (1989).
Osbourn et al.,Immunotechnol., 2:181 (1996).
Oseroff et al.,Proc. Nat'l Acad. Sci USA, 83:8744 (1986).
Oseroff et al.,Photochem. Photobiol., 46:83 (1987).
Papanikos et al.,J. Am. Chem. Soc., 123:2176 (2001).
Patt et al.,App. Radiat. Isotopes, 57:705 (2002).
Pèlegrin et al.,Cancer, 67:2529 (1991).
Potter et al.,Cancer Res., 58:2646 (1998).
Ridder et al.,Bio/Technol., 13:255 (1995).
Riechmann et al.,Nature, 332:323 (1988).
Rodriguez et al.,J. Org. Chem., 63:7134 (1998).
Sandhu,Crit. Rev. Biotech., 12:437 (1992).
Tarli et al.,Blood, 94(1):192 (1999).
Tatsuta et al.,Lasers Surg. Med., 9:422 (1989).
Tomizuka et al.,Nature Genet., 16:133 (1997).
van den Bergh,Chem. Britain, 22:430 (1986).
Vaughan et al.,Nature Biotech., 14:309 (1996).
Verhoeyen et al.,Science, 239:1534 (1988).
Wang et al.,Cancer Res., 52:4484 (1992).
Wang et al.,Proc. Natl. Acad. Sci USA, 100(1):56 (2003).
Ward et al., “Genetic Manipulation and Expression of Antibodies”,Monoclonal Antibodies: Principles and Applications, pp. 137-185 (1995).
Wester et al.,Eur. J. Nucl. Med. Molec. Imag., 30(1):117 (2003).
Winter et al.,Ann. Rev. Immunol., 12:433 (1994).
Yang et al.,Appl. Environ. Microbiol., 64(8):2869 (1998).
Yu et al.,Int. J. Cancer, 56:244 (1994).
Zhu et al.,Bio/Technol., 14:192 (1996).
Zhu et al.,J. Org. Chem., 68:5641 (2003).
Barthel et al., “3′-deoxy-3′-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography”, Cancer Res. Jul. 1, 2003;63(13):3791-8.
Haubner et al., “Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography”, Cancer Res. Mar. 1, 2001;61(5):1781-5.
Sorger et al., “[18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors”, Nucl Med Biol. Apr. 2003;30(3):317-26.
Supplementary European Search Report for EP 04821595.8 completed Aug. 19, 2010.
Goldenberg David M.
McBride William J.
Hartley Michael G
Immunomedics Inc.
Nakashima Richard A.
Perreira Melissa
LandOfFree
Fluorinated carbohydrate conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fluorinated carbohydrate conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fluorinated carbohydrate conjugates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4255064